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Rice University, Houston, TexasABSTRACT Although the magnitude of a protein’s net charge (Z) can control its rate of self-assembly into amyloid, and its
interactions with cellular membranes, the net charge of a protein is not viewed as a druggable parameter. This article demon-
strates that aspirin (the quintessential acylating pharmacon) can inhibit the amyloidogenesis of superoxide dismutase (SOD1) by
increasing the intrinsic net negative charge of the polypeptide, i.e., by acetylation (neutralization) of multiple lysines. The pro-
tective effects of acetylation were diminished (but not abolished) in 100 mM NaCl and were statistically significant: a total of
432 thioflavin-T amyloid assays were performed for all studied proteins. The acetylation of as few as three lysines by aspirin
in A4V apo-SOD1—a variant that causes familial amyotrophic lateral sclerosis (ALS)—delayed amyloid nucleation by 38%
and slowed amyloid propagation by twofold. Lysines in wild-type- and ALS-variant apo-SOD1 could also be peracetylated
with aspirin after fibrillization, resulting in supercharged fibrils, with increases in formal net charge of ~2 million units. Peracety-
lated SOD1 amyloid defibrillized at temperatures below unacetylated fibrils, and below the melting temperature of native
Cu2,Zn2-SOD1 (e.g., fibril Tm ¼ 84.49C for acetylated D90A apo-SOD1 fibrils). Targeting the net charge of native or misfolded
proteins with small molecules—analogous to how an enzyme’s Km or Vmax are medicinally targeted—holds promise as a strat-
egy in the design of therapies for diseases linked to protein self-assembly.INTRODUCTIONCoulombic forces drive the intermolecular repulsion and
attraction of protein molecules at distances up to 10 A˚ in
physiological buffer and possibly longer if the interaction
occurs across the hydrophobic interior of a protein or lipid
bilayer (1,2). Although these far-reaching forces scale
with each protein’s magnitude of net positive or net negative
charge (Z), the net charge of a protein has never been scru-
tinized as a medicinal target that can be permuted with a
small molecule. Instead, small molecule drugs that target
proteins are designed to affect other classical parameters
such as Km, Vmax, Kd, and DG
z
fold, by the introduction of
hydrophobic, dipolar, or H-bonding interactions (3–5).
Developing drugs that can increase the magnitude of net
charge of a protein—for example, making an anionic pro-
tein more anionic—and thereby control intermolecular
interactions electrostatically, might be effective in com-
bating diseases that are linked to protein self-assembly,
such as amyotrophic lateral sclerosis (ALS) (6). ALS, a
currently untreatable and a fatal neurodegenerative disease,
is characterized by the selective, progressive death of motor
neurons. More than 150 different mutations in the gene en-
coding superoxide dismutase-1 (SOD1) cause familial ALSSubmitted September 22, 2014, and accepted for publication January 13,
2015.
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0006-3495/15/03/1199/14 $2.00by a gain of function mechanism (6). What this function
might be is still unclear but one leading hypothesis suggests
that SOD1 mutations cause ALS by accelerating the rate of
self-assembly of SOD1 into oligomers that are, for some
unknown reason, toxic to motor neurons (6). The self-as-
sembly of wild-type (WT) SOD1 is also suspected to cause
certain cases of sporadic (nonfamilial) ALS (6). The exact
stoichiometry, morphology, and structure of neurotoxic
SOD1 oligomers (assuming that such oligomers cause
ALS) have not been determined, although several studies
point to amyloid-like SOD1 oligomers as toxic species (7).
In this article, we describe a first-order proof of this
charge-boosting principle by demonstrating that lysine res-
idues in WT- and ALS-linked SOD1 can be acetylated with
an aryl ester drug (acetylsalicylic acid; aspirin), both before
and after the fibrillization of SOD1 into amyloid (Fig. 1).
We find that the nonspecific acetylation of as few as three
lysines (out of 11) in a subunit of A4V apo-SOD1—a reac-
tion that increases the magnitude of net negative charge of
SOD1 (pI ¼ 5.9)—delayed the nucleation of amyloid fibril-
lization by up to 5 h and decreased the rate of fibril propa-
gation by twofold (Table 1). This diminished rate of
nucleation is similar to, and the rate of propagation is slower
than that of unacetylated WT apo-SOD1.
We chose acetylsalicylic acid in this proof of concept
study because it acetylates serine and lysine residues in
multiple proteins in vivo (8,9) (in addition to acetylatinghttp://dx.doi.org/10.1016/j.bpj.2015.01.014
FIGURE 1 Chemically boosting the net charge (Z) of SOD1. The accu-
mulation of acetyl modifications on native or oligomeric SOD1 by repeated
doses of an acylating agent is plausible when considering the long lifetime
of native SOD1 in motor neurons (27), and the generally long lifetime of
amyloid oligomers in vivo (28,29). (A) The net charge of dimeric WT
SOD1 has been measured to vary from ~3.7 to ~12.1, depending on
the metalation state and subcellular pH (25). Acetylation of lysine residues
in native SOD1 will increase the magnitude of net negative charge by
between 15% and 50%, depending on subcellular pH and metalation state.
(B) Peracetylating lysine residues in an amyloid fibril of SOD1 (d¼ 15 nm,
l¼ 2 mm) with aspirin is expected to increase the magnitude of net negative
charge by ~106 formal units. To see this figure in color, go online.
1200 Abdolvahabi et al.serine in its primary target, cyclooxygenase-1; COX1) (9).
Aspirin was recently found to acetylate lysine and serine
in 120 different proteins in cultured cells (10), but its re-
action with SOD1 has never been reported, either in vivo
or in vitro. Aspirin also exhibits therapeutic effects in
several diseases (9) and has mysteriously beneficial ef-
fects in ALS-SOD1 transgenic mouse models (11). The
acetylation of lysine is a posttranslational modification
that is involved in controlling multiple cellular processes
such as cell signaling, nucleic acid binding, gene ex-
pression, protein-protein interactions, and enzymatic
activity (12).
The charge-boosting hypothesis was inspired, and is sup-
ported by the following: 1) the inverse correlation between
the magnitude of a protein’s net charge and its rate of self-
assembly into amyloid and nonamyloid aggregates (13,14)
(including the historical observation that proteins precipitate
rapidly at their isoelectric point (15,16)); 2) the naturally
small net charge of proteins (~80% are predicted to have
net charges between þ10 and 10, with median Z ¼ 3)
(17); 3) the observation that lysine acetylation can prevent
protein precipitation by increasing net negative charge
(18,19); 4) observations that the permeability of a protein
across glycated, anionic cellular membranes—a processBiophysical Journal 108(5) 1199–1212that might be requisite for the cell-to-cell, prion-like propa-
gation of aggregated SOD1 (20)—can be abolished by in-
verting the protein’s sign of net charge from positive to
negative (21); and 5) the occurrence of cryptic ALS muta-
tions in sod1 (e.g., D90A, D101N, E100K, and N139K)
that do not appear to alter the structure, stability, enzymatic
activity, or metal binding properties of the SOD1 native
state, but do neutralize its net negative charge (22,23).
Although these cryptic substitutions might promote aggre-
gation by altering local patterns of net charge, their scat-
tering across SOD1’s surface suggests that neutralizing the
negative surface potential at multiple loci is sufficient to
trigger ALS, or equally and alternately, that neutralizing
the net negative charge of SOD1 is sufficient for pathogen-
esis (24).
The use of a small molecule to increase the net charge of a
folded protein is complicated by the absence of experimen-
tally determined values of net charge for nearly all folded
proteins. We estimate that the net charge of <0.1% of pro-
teins in the Protein Data Bank have been measured, at pIs
pH (24,25). Recently, we used protein charge ladders and
capillary electrophoresis (CE) to show that the measured
net charge (denoted ZCE) of WT- and ALS-variant SOD1
can deviate (in sign and magnitude) from predicted values
(denoted Zseq) at certain metal stoichiometries and sub-
cellular pH (24,25). At pH 7.4, the net charge of WT
Cu2,Zn2-SOD1 was ZCE ¼ 7.37 charge units per dimer
(Zseq ¼ 8.2); and the net charge of apo-SOD1 was
ZCE ¼ 12.13 units per dimer (Zseq ¼ 13.0). At pH 5.0
(i.e., the pH of the lysosome, one of SOD1’s subcellular
loci (26)), the net charge of WT Cu2,Zn2-SOD1 was only
ZCE ¼ 3.7 units per dimer, which is opposite in sign
and eight units more negative than the predicted value of
Zseq ¼ þ4.0 (25). The net charge of WT apo-SOD1 could
not be determined at pH 5, presumably because SOD1 ap-
proached Z ¼ 0 and precipitated during CE (25). Neverthe-
less, the acetylation of a single lysine in a subunit of WT
SOD1 is expected to increase its magnitude of net negative
charge by ~15% to 50% (per subunit), depending on its state
of metalation and subcellular locus (Fig. 1 A). The effects of
lysine acetylation on certain ALS-variant SOD1 proteins
(e.g., D90A, G93R, E100K) will be even larger, as these
proteins teeter on the edge of electrostatic neutrality at phys-
iological pH (24).MATERIALS AND METHODS
Purification of WT- and ALS-variant apo-SOD1
Detailed descriptions of all experimental procedures can be found in the
Supporting Material. Briefly, human WT, D90A, and A4V SOD1 proteins
were recombinantly expressed in Saccharomyces cerevisiae, purified, de-
metallated, and characterized as previously described (25). The absence
of metals was confirmed after demetallation (and again after acetylation)
with inductively coupled plasma mass spectrometry (ICP-MS), as previ-
ously described (25).
TABLE 1 Rate of nucleation and propagation of amyloid fibrils ofWT- and ALS-variant apo-SOD1 as a function of lysine acetylation,
Ac(N)
SOD1a Ac (~N)b
0 mM NaCl (n ¼ 18) 100 mM NaCl (n ¼ 18)
Lag time (h) (DLag time)c 1/k (h)c (D1/k)d P-valuee Lag time (h) (DLag time)d 1/k (h)b (D1/k)d P-valuee
WT 0 13.95 1.1 1.15 0.1 15.45 1.1 1.8 5 0.1
1 15.05 1.2 (1.15 1.6) 2.25 0.2 (1.15 0.2) 0.48 17.65 1.6 (2.25 1.9) 2.75 0.2 (0.95 0.2) 0.27
3 16.55 0.7 (2.65 1.3) 2.65 0.1 (1.55 0.1) 0.06 16.95 0.8 (1.55 1.4) 2.45 0.1 (0.65 0.1) 0.28
6 24.95 1.3 (11.05 1.7) 3.35 0.3 (2.25 0.3) <0.0001 25.55 0.9 (10.15 1.4) 3.25 0.3 (1.45 0.3) <0.0001
D90A 0 11.95 1.0 2.15 0.2 9.3 5 0.9 1.5 5 0.2
2 11.15 1.1 (0.8 5 2.1) 3.35 0.3 (1.25 0.5) 0.57 14.05 1.1 (4.75 1.4) 2.15 0.2 (0.65 0.2) 0.002
3 9.8 5 1.1 (2.1 5 2.1) 3.45 0.2 (1.35 0.4) 0.15 14.15 1.1 (4.85 1.4) 2.25 0.2 (0.75 0.2) 0.002
5 12.45 1.2 (0.55 1.6) 3.85 0.2 (1.75 0.2) 0.76 15.25 1.4 (5.95 1.7) 2.65 0.2 (1.15 0.2) 0.001
A4V 0 13.85 1.7 2.25 0.2 12.75 1.3 2.2 5 0.3
3 20.15 2.1 (6.35 2.7) 4.15 0.4 (1.95 0.4) 0.02 17.55 1.3 (4.85 1.3) 4.85 0.3 (2.65 0.3) 0.01
4 11.55 0.7 (2.3 5 1.8) 3.25 0.3 (1.05 0.4) 0.21 15.65 2.2 (2.95 2.5) 4.65 0.5 (2.45 0.6) 0.26
9 28.35 1.7 (14.55 1.7) 4.95 0.3 (2.75 0.4) <0.0001 17.15 1.2 (4.45 1.3) 4.75 0.4 (2.55 0.5) 0.02
aAll acetylated and unacetylated SOD1 proteins were in the metal free state with <0.065 0.02 Zn2þ and < 0.035 0.01 Cu2þ bound per SOD1 dimer.
bMean number of acetylated residues, per apo-SOD1 monomer, as inferred from CE and MS.
cRate of propagation expressed as inverse propagation constant (1/k).
dDLag time and Dpropagation values are expressed relative to Ac(0) for each protein. All values and errors are listed as mean5 SE from 18 replicate ThT
assays for each sample; the R2 values of all fits were >0.98.
eThis table only lists p-values comparing the lag time of acetylated proteins with unacetylated protein; all p-values comparing 1/k values of acetylated vs.
unacetylated protein were ~p < 0.005.
Net Charge as a Druggable Target 1201Acetylation of WT- and ALS-variant apo-SOD1
with aspirin
Crystalline acetylsalicylic acid was purchased from Sigma-Aldrich (purity
> 99.0%) and used for the acetylation of lysine residues in WT- and ALS-
variant apo-SOD1 (see Supporting Material for additional details). All
solutions and buffers were made with ultrapure metal-free water with a
measured resistance of 18.2 MU/cm (dispensed through a Millipore MilliQ
system). All containers used for making buffers or other solutions were
rinsed with 5 mM EDTA and pure water before use. Peracetylated apo-
SOD1 fibrils were also prepared by adding crystalline acetylsalicylic acid
to aqueous solutions of unacetylated amyloid fibrils of apo-SOD1. Reaction
byproducts (acetic acid, salicylic acid) and unreacted aspirin were removed
by centrifugation and the discarding of supernatant. An identical aliquot of
unmodified fibrils was set aside and not reacted with aspirin and functioned
as a negative control. The buffer in which fibrils were suspended was
changed to 10 mM potassium phosphate, 5 mM EDTA, pH 7.4 (for thermal
stability assays) via centrifugation, and removal of supernatant followed by
addition of fresh buffer. After acetylation, all apo-SOD1 proteins were
analyzed with ICP-MS to confirm the absence of metal ions.Biophysical characterization and mass
spectrometric analysis of native and fibrillar
apo-SOD1 proteins
Analysis of acetylated and unacetylated apo-SOD1 proteins with CE, dif-
ferential scanning calorimetry, transmission electron microscopy, mass
spectrometry (MS), and tandem mass spectrometry (MS/MS) was per-
formed as previously described (27,30). MS/MS analysis was performed
to characterize the types of acetyl-regioisomers that likely formed on
nonspecific acetylation with aspirin. The effect of lysine acetylation on
the structure of SOD1 proteins was also analyzed with amide hydrogen/
deuterium exchange (H/D) and MS, as previously described (see Support-
ing Material for additional details). Measuring H/D exchange with MS al-
lowed each acetyl derivative to be analyzed simultaneously under identical
pH, and temperature, thus eliminating the sample-to-sample experimental
variation that often occurs during H/D exchange-MS. To determine the
identity of acetylated residues on fibrillar apo-SOD1, LC-MS and MS/MS analysis was performed after fibril dissociation to monomeric SOD1.
Fibrils were dissociated by incubation in 6.5 M guanidinium hydrochloride
(Gdm-HCl), 20 mM dithiothreitol (DTT) at 50C for 1 h. This thermochem-
ical defibrillization protocol has been previously shown to be adequate for
dissociating amyloid fibrils of apo-SOD1 (31).Fluorescent kinetic assays for apo-SOD1 proteins
Thioflavin-T (ThT) fluorescence assays for apo-SOD1 fibrillization were
performed in a sealed 96-well microplate as previously described (27).
To acquire statistically meaningful lag times and propagation rates, we per-
formed 18 replicates of ThTassays for each of the three apo-SOD1 proteins
and their four sets of acetylated derivatives, in the absence and presence of
100 mM NaCl, amassing a total of 432 separate assays. For any set of acet-
ylated proteins, each of the 18 replicates was performed simultaneously in
the same 96-well plate, on solutions of SOD1 taken from the same stock of
acetylated or unacetylated SOD1. Before aggregation assays, solutions
were filtered with a syringe filter (0.2 mm hydrophilic polypropylene,
Acrodisc Pall Co., Port Washington, NY) to remove any type of high mo-
lecular weight oligomers of apo-SOD1 (or other colloids) that might seed
or catalyze fibrillization. The concentration and purity of apo-SOD1 was
confirmed with reducing sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE) immediately before the initiation of each aggrega-
tion assay and at the completion of the assay. The volume of each well was
also measured at the end of the assay (with a micropipette) to ensure that
evaporation did not occur during the aggregation assay.Thermal stability assays for supercharged fibrillar
apo-SOD1 proteins
The thermal stability of the unacetylated and acetylated apo-SOD1 fibrils
was determined with a thermal defibrillization assay that was adapted
from a previous study by Shammas et al. (32). Fibril homogenate from
both acetylated and unacetylated fibrils of apo-SOD1 (in 10 mM potassium
phosphate, 5 mMEDTA, pH 7.4) were aliquoted into ten different tubes that
were each heated to a specific temperature between 40C to 130C. The
temperature was raised at an average rate of 0.5 to 1.0C/min (similar to
a typical heating rate during differential scanning calorimetry). To reachBiophysical Journal 108(5) 1199–1212
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(Mastercycler, Eppendorf, Hamburg, Germany). For temperatures above
100C, a heat block was used (VWR, Radnor, PA). To avoid solvent evap-
oration during heating above 100C, we used a pressurized external lid that
was designed to cover the sample vials (that reached pressures of
~350 kPa). At each temperature, a tube of protein solution was cooled
and centrifuged at 17,000  g (4C) for 30 min and the supernatants
were analyzed with ultraviolet-visible spectrophotometry (240 to
300 nm). Thus, the thermal defibrillization of the fibrils was detected by
the retention of soluble, nonsedimentable SOD1 in the supernatant. The
same four-parameter sigmoidal function that was fitted to the ThT fibrilli-
zation data (Eq. 1 in the Supporting Material) was fitted to the data points
from the thermal defibrillization assays using SigmaPlot, version 11.0 (Sy-
stat Software, Chicago, IL); see Fig. S1. The inflection point of the sigmoid,
x0, was reported as the melting temperature (Tm) of the amyloid fibrils.
The relative molecular weights of nonsedimentable species that might be
left over from the thermal defibrillization assays—i.e., melted fibrils, which
still might exist as low molecular weight oligomers—were determined with
size-exclusion liquid chromatography (SE-LC) and native PAGE. See Sup-
porting Material for additional details.Estimating the net charge of fibrillar apo-SOD1
The magnitude by which peracetylation affected the net charge of apo-
SOD1 fibrils was estimated by approximating the number of SOD1 chains
in an average-sized SOD1 fibril, and assuming that each lysine acetylation
increased the net negative charge of the polypeptide by 0.9 units (instead of
1.0 unit), because of charge regulation (2). The number of SOD1 subunits in
each fibril was approximated by estimating the molecular volume of mis-
folded SOD1 as described in the Supporting Material, based on a spherical
approximation (33).FIGURE 2 Acetylation of multiple lysines in WT- and ALS-variant apo-
SOD1 by aspirin. Electrospray ionization mass spectra of soluble (A) WT,
(B) D90A, and (C) A4V apo-SOD1 after reaction with different concentra-
tions of aspirin (in aqueous buffer). The mean number of acetylated lysines
are denoted as Lys-Ac(~N), and are listed per apo-SOD1 monomer. To see
this figure in color, go online.RESULTS AND DISCUSSION
Acetylation of lysine in dimeric WT- and
ALS-variant apo-SOD1 with acetylsalicylic acid
MS and CE showed that the reaction of 25 to 150 mM
aspirin with native WT- or ALS-variant apo-SOD1 resulted
in chemical arrays of apo-SOD1 proteins with varying
degrees of acetylation per monomer (denoted ‘‘Ac(~N),’’
Figs. 2 and S2). These aspirin concentrations are consider-
ably higher than peak concentrations of intact (unhydro-
lyzed) acetylsalicylic acid in human plasma, which reach
30 to 150 mM (depending on dosage); concentrations of
salicylic acid reach as high as 2.5 mM (9). The degree of
acetylation for each mixture is expressed as the mean num-
ber of acetyl modifications in each mixture per monomer, as
measured by MS and CE (Figs. 2 and S2). The mean number
of acetylated lysines was determined from a Gaussian distri-
bution of the MS charge ladders. Each acetylation is associ-
ated with aþ42 Da increase in mass, Fig. 2, A–C. At 25 mM
aspirin, approximately one lysine (mean) was acetylated in
each WT apo-SOD1 monomer; two lysines per monomer in
D90A; and three lysines per monomer in A4V apo-SOD1
(MS/MS sequencing is discussed below and in the Support-
ing Material). At 150 mM aspirin, the mean acetylation
observed for WT apo-SOD1 was six lysines per monomer;
five lysines per monomer for D90A; and nine lysines per
monomer for A4V apo-SOD1 (Fig. 2 and Table S1).Biophysical Journal 108(5) 1199–1212Each of these acetylated arrays (charge ladders) of WT
and D90A apo-SOD1 were partially resolvable with CE,
wherein each acetylation increased the electrophoretic
mobility, i.e., increased the net negative charge of SOD1
(Fig. S2, A–C). The capillary electropherogram of A4V
apo-SOD1 exhibited poor resolution (Fig. S2 C), possibly
because of its well-known dimer instability and dynamic
structure (34). Proteolysis and MS/MS confirmed that
each modification occurred on lysine; no other acetylated
residues were detected in WT, D90A, or A4V apo-SOD1,
with the following exception: in A4V apo-SOD1, we de-
tected (via MS/MS analysis) a small amount of acetylation
on Thr-88 and Ser-105, but only at [aspirin] ¼ 150 mM
FIGURE 3 Fibrillization of unacetylated (top) and acetylated (bottom)
apo-SOD1 (0 mM NaCl) as measured by thioflavin-T fluorescence in a
96-well microplate. Eighteen plots of thioflavin-T fluorescence from 18
replicate amyloid assays of WT apo-SOD1-Ac(0) (top) and WT apo-
SOD1-Ac(~6) (bottom) carried out simultaneously in the same 96-well mi-
croplate. Each of the 18 aliquots were taken from the same stock solution of
acetylated or nonacetylated SOD1 and analyzed simultaneously in the same
96-well microplate to eliminate variations in solution conditions and mini-
mize random error. Black arrows identify the outlier sigmoids in the data
set. The raw plots of ThT fluorescence for other acetyl derivatives of WT
apo-SOD1 (and D90A and A4V) can be found in the Supporting Material
(Figs. S6–S11). The average number of acetylated lysines (Ac(~N)) is listed
per apo-SOD1 monomer. To see this figure in color, go online.
Net Charge as a Druggable Target 1203(Fig. S4). We were not able to add sufficient aspirin to per-
acetylate any of the three SOD1 proteins because each pro-
tein began to precipitate after the addition of >150 mM
aspirin.
The acetylation of nine lysines in WT and D90A apo-
SOD1 was apparently nonspecific according to MS/MS
(Table S1). For example, at least nine out of 11 lysines
were acetylated in WT or D90A apo-SOD1 regardless of
the mean acetylation. Lys-3 and Lys-91, however, were
not acetylated in WT and D90A apo-SOD1 at any concen-
tration of aspirin, except 150 mM aspirin, wherein Lys-91
was found to be acetylated in WT apo-SOD1 (Table S1).
In contrast, the acetylation of all 11 lysines in A4V apo-
SOD1 by aspirin was nonspecific. For example, a solution
of A4Vapo-SOD1 with a mean number of three acetylations
per monomer was found with MS/MS to contain acetyl
modifications on all 11 lysines (Table S1). See Supporting
Material for additional discussion of the MS/MS data.
Thus, each rung in the charge ladder consisted of a mixture
of regioisomers. If we assume that all 11 lysines in a mono-
meric SOD1 protein are equally reactive (which is unlikely,
considering that each lysine likely has its own specific pKa),
then the maximum number of statistically possible re-
gioisomers (r) can be expressed by r ¼ 11!/[N!(11-N)!],
where N is the number of acetylated lysines for that partic-
ular rung. For example, r ¼ 11 for Ac (1); r ¼ 55 for Ac (2),
and r ¼ 165 for Ac (3). The actual number of regioisomers
that exist in solution is likely to be lower than the statisti-
cally possible maximum because of the disparate reactivity
of each lysine (i.e., the unique solvent accessibility or pKa of
each lysine), especially in the case of WT and D90A apo-
SOD1 where Lys-3 and Lys-91 appear to be less reactive
than the other nine lysines (Fig. S3).
The concentration of each rung could be approximated
from its mass spectrum. For example, the A4V apo-SOD1-
Ac(~3) protein consisted of 3.6% Ac (0), 10.9% Ac (1),
19.5% Ac (2), 22.6% Ac (3), 16.8% Ac (4), 16.7% Ac
(5), and 9.9% Ac (6) (Figs. S2 C, red spectrum, and S5 C).Aspirin inhibits amyloidogenesis of WT- and
ALS-variant apo-SOD1 by acetylation of lysine
The rates of amyloid formation forWT, A4V, and D90A apo-
SOD1 (acetylated and unacetylated forms) were measured
under reducing conditions (10 mM TCEP) with a thio-
flavin-T (ThT) fluorescence assay (35), in replicates of
n ¼ 18 for each derivative of each protein. The longitudinal
plots of ThT fluorescence from each experiment exhibited a
sigmoidal increase in fluorescence at 485 nm. A set of 18 of
these raw, unnormalized sigmoids are shown, as an example,
for WT-Ac(0) and WT-Ac(~6) (Fig. 3). All other sets of
sigmoidal plots for all three proteins (at different degrees
of acetylation, with and without 100 mM NaCl) are pre-
sented in Figs. S6–S11. To increase visual clarity, each set
of 18 replicate plots of ThT fluorescence were also averaged(combined) into a single sigmoid for each set of acetyl deriv-
atives and are shown for all three SOD1 proteins in Figs. 4,
A–C (0 mM NaCl) and 5, A–C (100 mM NaCl).
The high number of replicate assays (i.e., a total of 432
amyloid assays) was necessary to acquire statistically sig-
nificant fibrillization rates because the fibrillization of
apo-SOD1 in the microplate-based ThT assay is apparently
stochastic (as previously observed for unacetylated SOD1
(27)). By stochastic, we do not mean entirely random, but
rather nondeterministic, i.e., that the measured rates of am-
yloid formation in each well will fall within some type of
mathematical distribution (e.g., Gaussian or Lorentzian)
wherein the mean or maximum of the distribution is the
best expression of the rate of the process. Whether or not
the nucleation of amyloid can occur through a stochastic
mechanism is apparently controversial. Stochastic nucle-
ation is nevertheless observed in other self-assembled
systems, at all scales of size and complexity, from theBiophysical Journal 108(5) 1199–1212
FIGURE 4 Effect of lysine acetylation on the rate of fibrillization of WT-
and ALS-variant apo-SOD1 in 0 mM NaCl. Thioflavin-T fluorescence
assays of unacetylated and acetylated (A) WT, (B) D90A, and (C) A4V
apo-SOD1 proteins (pH 7.4, 37C). Each curve is an average of normalized
fluorescence measurements from 18 separate replicate experiments (of the
sort shown in Fig. 3). Transmission electron micrographs of fibrillar forms
of acetylated (D) WT, (E) D90A, and (F) A4V apo-SOD1 after the ThT
assay. The mean number of acetylated lysines is denoted as Lys-Ac(~N),
per apo-SOD1 monomer. Table 1 and Fig. S12 list p-values for all kinetic
analyses extracted from ThT fluorescence assays. To see this figure in color,
go online.
FIGURE 5 Effect of lysine acetylation on the rate of fibrillization of WT-
and ALS-variant apo-SOD1 in 100 mM NaCl. Thioflavin-T fluorescence
assays of unacetylated and acetylated (A) WT, (B) D90A, and (C) A4V
apo-SOD1 proteins (pH 7.4, 37C). Each curve is an average of data
(normalized) from 18 separate replicate experiments. The mean number
of acetylated lysines is denoted as Lys-Ac(~N), per apo-SOD1 monomer.
(D–F, upper panels) Transmission electron micrographs of fibrillar forms
of acetylated WT, D90A, and A4V apo-SOD1 after the ThT assay in
100 mM NaCl. (D–F; lower panels) SDS-PAGE of samples before (left)
and after (right) ThT aggregation assay in 100 mM NaCl. The gels on the
right in each panel are from supernatants of samples after aggregation
and centrifugation. Table 1 and Fig. S13 list p-values for all kinetic analyses
extracted from ThT fluorescence assays. To see this figure in color, go
online.
1204 Abdolvahabi et al.crystallization of water (36), to the cAMP-induced aggrega-
tion of social amoeba (37). The nucleation of amyloid fibrils
has been observed (and described) to be stochastic for
proteins including Ab1-40, b2-microglobulin, and insulin
(38–42). Even in reports that describe amyloid nucleation
as a nonstochastic, deterministic process, these studies still
report large, unexplained variations in lag times of replicateBiophysical Journal 108(5) 1199–1212measurements (e.g., the lag time of nucleation of Ab1-42
varied from 24 to 17 h in replicate measurements made by
Hellstrand and coworkers (43)).
The rate of nucleation of amyloid fibrils is expressed as
the lag time and the propagation of fibrils (elongation) is
expressed as the inverse rate constant of propagation (1/k,
i.e., the steepness of the sigmoid), as previously described
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parameterization. The lag time and inverse propagation con-
stants in Table 1 are average values calculated from 18 indi-
vidual fits of the 18 replicate amyloid assays. An unpaired
Student’s t-test was used to verify the statistical significance
of any measured differences in the lag time and propagation
rate for acetylated and unacetylated proteins (at a 95% con-
fidence interval). Figs. S12 and S13 show p-values. Addi-
tional mathematical parameters from the sigmoidal fits of
fluorescence data (i.e., a, x0, b, and x0-2b from Eq. 1 in
the Supporting Material, and R2 values for fits) are also
listed in Tables S2–S4.
We also experimented with calculating parameters such
as lag time by first averaging all longitudinal fluorescence
data into a single sigmoid and then performing a single non-
linear regression analysis of the average sigmoid (wherein
each point in the sigmoid contains its own error). This
method produced similar average values of lag time com-
pared with the above method, but with error values that
were, in our opinion, unrealistically small (e.g., tenfold
smaller). For example, the average lag time for WT Ac(0)
(0 mM NaCl) was calculated to be t ¼ 13.9 5 1.1 h when
each sigmoid (data) set was analyzed individually with
nonlinear regression analysis (Table 1), compared with t ¼
14.7 5 0.1 h when individual sigmoidal data plots were
averaged into a single sigmoid and analyzed with a single
nonlinear regression analysis. Thus, we chose to report lag
times (in Table 1) as averages of 18 separate nonlinear
regression analyses for each derivative of each protein.
Many of the longitudinal plots of ThT fluorescence show
a decrease in fluorescence after fibrillization is complete
(Figs. S6–S11). This artifactual decrease has been previ-
ously observed (27) and was not included in sigmoidal
fitting or the calculation of lag time and propagation rate.
This decrease in fluorescence is likely caused by the adhe-
sion of aggregated protein to the side of the polystyrene
wells of the microplate, as inferred from visual inspection
of each well at the end of the aggregation assay.
The elongation (propagation) of amyloid fibrils of acety-
lated WT, A4V, and D90A apo-SOD1 was consistently
slower (i.e., 1/k was consistently larger) than the unacety-
lated protein, both in the presence and absence of 100 mM
NaCl (Table 1 and Figs. 4 and 5). In general, the rate of elon-
gation of amyloid fibrils of maximally acetylated apo-SOD1
proteins was slower than minimally acetylated forms (with
the exception of A4V, wherein Ac(~3) and Ac(~9) elongated
at similar rates). Acetylation of each apo-SOD1 protein also
increased the lag time of amyloid, but with some acetyl de-
rivatives, these effects were less uniform and not statistically
significant (Table 1), e.g., with D90A in 0 mMNaCl (Table 1
and Fig. S12 C). Nevertheless, acetylation inhibited the
formation of amyloid by either increasing the lag time or
slowing fibril propagation, and in most cases by both
increasing lag time and slowing propagation (Table 1 and
Figs. S11 and S12).When comparing the effects of acetylation on the average
value of lag time and fibril propagation, it is important to
remember that the set of 18 replicate sigmoidal plots of
ThT fluorescence for each protein in Figs. 3 and S6–S11 in-
cludes, in some cases, outlier sigmoids. We did not use a
Dixon’s Q-test to exclude outlier sigmoids with outlying
lag times and/or propagation rates. Although such outliers
(e.g., the far right sigmoids in Fig. 3) can skew averages,
these outliers cannot be excluded because we have no reason
to suspect that experimental errors occurred in the collection
of these data. We do not suspect that the presence of outlier
sigmoids is caused by differences in solution conditions
because assays were carried out on identical solutions that
were simply aliquoted into different wells of the sealed mi-
croplate. The presence of a heterogeneous distribution of
acetyl derivatives or regioisomers in any particular solution
cannot explain why different aliquots of the same solution
exhibit outlier kinetics because even the unacetylated
SOD1 protein—which is chemically monodisperse/homog-
enous—exhibited outlier kinetics. For example, wells that
contained unacetylated WT SOD1-Ac(0) (in 0 mM NaCl)
exhibited lag times from ~6 to 28 h, within the same micro-
plate and experiment (Fig. 3). Thus, it is necessary to not
only compare average values of lag time and propagation,
but to also compare probabilities (p-values) of similarity
among different data sets (Table 1).
We do not know why we observe the nucleation and ag-
gregation of SOD1 to be effectively stochastic, that is, why
identical, aliquoted solutions of SOD1, analyzed at the
same time in the same sealed microplate, with the same in-
strument, occur at different rates. The nucleation of amyloid
SOD1 might be best described by nonclassical nucleation
theory, wherein the DH and DS of the various nuclei that
might form are different than the DH and DS of the final
bulk assembly (27,44,45). A zeroth-order approximation
(using the Arrhenius equation) would suggest that variations
in the Ea of amyloid nuclei or the collision frequency of
SOD1 proteins give rise to the nondeterministic rates. Vari-
ations in Eamight be caused by a random element within the
apo-SOD1 protein, such as one or both of its two intrinsi-
cally disordered metal binding loops, which could result in
heterogeneous nuclei, that form and elongate with different
values of Ea (and thus whose relative concentrations vary
from well to well). We also note that the self-assembly
that we observe is likely to involve heterogeneous nucleation
wherein ions, or surfaces of the apparatus (i.e., the Teflon
bead or polystyrene microplate) contribute to the observed
rate of aggregation.
Avariation in the collision frequency of reactants, in each
well, might be caused by variations in the trajectory or
velocity of the Teflon bead in each well. Variations in
the mass of the machined Teflon bead (purchased from
McMaster-Carr) is an unlikely source of variation, as these
beads only vary in mass from 36.1 to 35.9 mg according to
our measurements. Variations in the temperature of eachBiophysical Journal 108(5) 1199–1212
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is temperature controlled. The presence of a dust particle or
preformed aggregate in some of the wells is also an unlikely
explanation as we filtered each solution immediately before
aggregation assay. Variations in volume (SOD1 concentra-
tion) cannot explain variations in rates of fibrillization
because all replicate solutions are aliquoted from the same
stock and the volume of each well was measured at the
end of an assay to ensure no evaporation through the sealed
lid. Varying degrees and types of nano-, micro-, or macro-
scopic surface imperfections (e.g., scratches) on the surface
of the bead or the well cannot yet be ruled out. Identifying
the source of the stochastic nature of SOD1 amyloidogene-
sis must be the subject of a future study.
The protective effect of acetylation against amyloid for-
mation was generally more pronounced in the absence
of 100 mM NaCl (Table 1 and Fig. S12) than in the presence
of salt (Table 1 and Fig. S13). This sensitivity to NaCl sug-
gests that lysine acetylation inhibited the nucleation and
propagation of amyloid by an electrostatic mechanism (at
least in part). Acetylation had the largest inhibitory effect
on the nucleation and propagation of A4V and WT apo-
SOD1 fibrils, and the smallest effect on the self-assembly
of D90A apo-SOD1 (regardless of NaCl concentration).
For example, in the absence of 100 mM NaCl, the acetyla-
tion of ~ three lysines per monomer in A4V and WT apo-
SOD1 resulted in an approximate twofold increase in the
inverse propagation constant for both proteins (i.e., a lower
rate of propagation), ***p< 0.0001 (Fig. S12). The lag time
of A4V-Ac(~3) fibrillization was also increased by 6.3 5
2.7 h, *p ¼ 0.0243 compared with A4V-Ac(0) (Table 1).
Moreover, A4V-Ac(~3) exhibited a lower lag time of fibril-
lization than the unacetylated WT apo-SOD1 protein. The
rate of aggregation for WT apo-SOD1 is not necessarily a
perfect benchmark for nontoxicity, because WT SOD1 is
causally linked to sporadic ALS (46) (but might require
chemical modification before aggregation (27)). Neverthe-
less, the slower aggregation of acetylated mutant SOD1
compared with WT SOD1 suggests that small increases
in the magnitude of a mutant protein’s net negative charge,
afforded by lysine acetylation, might impart a therapeutic
effect in ALS (or other diseases linked to protein self-
assembly).
In the absence of 100 mM NaCl, the maximally acety-
lated forms of WT and A4V (i.e., Ac > ~5) exhibited in-
creases in lag time of 11.0 5 1.7 h and 14.5 5 1.7 h,
respectively, compared with their unacetylated forms (Ta-
ble 1 and Figs. 4 and S12, ***p < 0.0001). Maximal acety-
lation of WT and A4Vapo-SOD1 also increased the inverse
propagation constant by 2.25 0.3 h (WT) and 2.75 0.4 h
(A4V), which corresponded to a 2.5-fold decrease in k (Ta-
ble 1 and Figs. 4 and S12, ***p< 0.0001). In the absence of
100 mM NaCl, the lag time of minimally acetylated D90A
apo-SOD1, i.e., Ac(~2), did not differ significantly from
unacetylated D90A apo-SOD1 (Table 1, Figs. 4 and S12,Biophysical Journal 108(5) 1199–1212p > 0.05), but the inverse propagation constant increased
by approximately twofold (Table 1 and Figs. 4 and S12,
***p ¼ 0.0007).
In 0 mM NaCl, A4V-Ac(~3) had a greater lag time of ag-
gregation than A4V-Ac(~4) by 8.65 2.3 h (but had similar
rates of propagation) (Table 1 and Fig. S12). This slower
aggregation, despite slightly lower acetylation, might arise
from difficulties in expressing mean acetylation. For ex-
ample, the Gaussian fitting of the MS spectrum of A4V-
Ac(~4) resulted in a mean acetylation of 3.8 Ac. Inspection
of the MS spectrum, however, demonstrated that the most
abundant peak is that of Ac (2) (Fig. 2 C). This difference
might explain why A4V-Ac(~4) was found to aggregate
faster than A4V-Ac(~3) in 0 mM NaCl (albeit, the rates of
A4V-Ac(~4) and A4V-Ac(~3) are statistically similar in
100 mM NaCl, Figs. 5 C and S13 F).
It is unlikely that the different rates of fibrillization that
we observed among WT- and ALS-mutant SOD1, and their
acetyl derivatives, are caused by Cu2þ or Zn2þ contamina-
tion. All SOD1 proteins were demetallated and con-
tained < 0.06 5 0.02 Zn2þ and < 0.03 5 0.01 Cu2þ per
SOD1 dimer after acetylation (according to ICP-MS). After
acetylation and analysis with ICP-MS, proteins solutions
were stored frozen until the initiation of the aggregation
assay. Each aggregation assay was also carried out in the
presence of 5 mM EDTA (to prevent metal contamination
from reagents used during the assay). Moreover, all solu-
tions and buffers were made with ultrapure metal-free water
with a measured resistance of 18.2 MU/cm (dispensed
through a Millipore MilliQ system). All containers used
for making buffers or other solutions were rinsed with
5 mM EDTA and pure water before use.
The addition of 100 mM NaCl at pH 7.4 increased the
overall rate of aggregation of each apo-SOD1 protein
(regardless of its degree of acetylation), which has been re-
ported previously for other proteins (47) (Figs. 5, A–C, and
S13). Although the presence of 100 mM NaCl generally
diminished—but did not abolish—the magnitude by which
acetylation slowed the rate of fibril initiation and pro-
pagation, the D90A apo-SOD1 protein was one exception
(Table 1). For example, the acetylation of five lysine resi-
dues had a negligible effect on the lag time of D90A fibril-
lization, in 0 mM NaCl, whereas the acetylation of five
lysines increased the lag time by 5.95 1.7 h in the presence
of 100 mM NaCl (Table 1 and Figs. 5, A–C, and S13, **p ¼
0.0022). Thus, acetylation had a greater effect on inhibiting
the fibrillization of D90A apo-SOD1 in 100 mM NaCl than
in 0 mM NaCl. Notably, in the presence of 100 mM NaCl,
the acetylation of A4V apo-SOD1 also slowed its fibrilliza-
tion to a value below that of unacetylated WT apo-SOD1
(Fig. S13).
The inability of Naþ and Cl- to completely screen the
electrostatic repulsions between negatively charged SOD1
proteins—i.e., to completely abolish the protective effects
of acetylation against aggregation—is not surprising and
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egy. Free cations and anions do not screen all types of inter-
molecular electrostatic interactions involving proteins (2),
especially, for example, when 1) the interaction occurs
through the low dielectric interior of a protein; 2) the inter-
action depends thermodynamically on desolvation of
charged groups; or 3) the electrostatic interaction occurs
over a distance that is smaller than the Debye screening
length (i.e., ~1 nm at I ¼ 0.1 M) (2). All three of these
criteria might exist within an initiating or elongating amy-
loid fibril.
To ensure that the inhibitory effects of acetylation on the
aggregation of apo-SOD1 were not attributable to differ-
ences (or errors) in protein concentration, and that solutions
did not contain soluble SOD1 at the end of the fluorescence
assay, we quantified the amount of nonsedimentable apo-
SOD1 proteins in solution at the start of the aggregation
assay and upon the completion of the assay. The concentra-
tion of all apo-SOD1 proteins, as measured by ultraviolet-
visible spectrophotometry, only varied by 5 2 mM before
the start of the assay (Fig. 5, D–F). SDS-PAGE also demon-
strated that all proteins were initially present at similar con-
centration and purity at the start of the assay (Fig. 5, D–F,
gels on left). The absence of SOD1 protein in the superna-
tant of solutions after completion of the aggregation assay
(and centrifugation) demonstrated that all acetylated and un-
acetylated apo-SOD1 proteins underwent aggregation into a
high molecular weight, sedimentable species (Fig. 5, D–F,
gels on right). We note that the acetylation of lysine residues
in apo-SOD1 decreased its electrophoretic mobility during
reducing SDS-PAGE, most likely because of a decrease in
bound SDS (as demonstrated by a recent study into the
long-standing mystery of abnormal protein migration during
SDS-PAGE (30)). Transmission electron microscopy
demonstrated that the high molecular weight aggregates of
acetylated and unacetylated apo-SOD1 were fibrillar in na-
ture (Figs. 4, D–F, and 5, D–F). The typical diameter of un-
acetylated and acetylated fibrils was ~15 to 20 nm, similar to
previous studies (48).Effect of lysine acetylation on the thermostability
and structure of the native state of apo-SOD1
The acetylation of lysine in a folded protein does not neces-
sarily lower its melting transition temperature (Tm) (18). To
determine if the acetylation of lysine diminished the rate of
aggregation of WT- and ALS-variant apo-SOD1 by
increasing apo-SOD1 thermostability, in addition to by
increasing net charge, we analyzed acetylated apo-SOD1
with differential scanning calorimetry, before fibrillization
(Fig. S14 and Table S5). The acetylation of lysine in WT-
and ALS-variant apo-SOD1 did not increase the thermosta-
bility of the native apo-protein, and therefore did not inhibit
fibrillization by increasing the Tm of the native protein
(Table S5). The acetylation of approximately six lysines(per monomer) in WT apo-SOD1, for example, lowered its
Tm by DTm ¼ 6.1C (Fig. S14 A). These DSC data show
that chemical modifications to a protein can inhibit self-as-
sembly even if the modification diminishes Tm of the native
state.
The acetylation of lysine in SOD1 by aspirin did not
disrupt the structure of the protein by a magnitude that re-
sulted in an increased rate of amide H/D exchange. Instead,
the acetylation of lysine in SOD1 proteins slightly dimin-
ished the rate of global amide H/D exchange by < 1 H per
acetyl modification (Fig. S14, D–F). This result is consistent
with previous reports showing that semi-random lysine acet-
ylation slows the rate of amide H/D exchange in proteins
(e.g., myoglobin, carbonic anhydrase, and SOD1) despite
also diminishing thermostability (18,24,25,49,50). The acet-
ylation of lysine has been hypothesized to slow amide H/D
exchange by a purely electrostatic mechanism, i.e., by not
altering H-bonding or solvent accessibility, but rather by
lowering the local concentration of the hydroxide catalyst
of H/D exchange and/or the activation energy of the divalent
anionic intermediate (R—N:——R1) (47). In the case of
A4V, the acetylated and unacetylated apo-protein exchanged
most of its amide hydrogens after only 5 min, which is
consistent with previous reports of its low thermostability.Acetylation of lysine in soluble apo-SOD1
diminishes the thermostability of resulting
amyloid fibrils
The cytotoxicity of an amyloid oligomer is thought to be
caused, in part, by its high thermostability, which inhibits
proteolysis by intracellular and extracellular proteases
(51). One important caveat is, however, that the breakage
of amyloid fibrils has been shown to increase cytotoxicity
by seeding amyloidogenesis and/or increasing membrane
permeability of oligomers (7). In the case of SOD1, this
latter hypothesis has not yet been rigorously (quantitatively)
tested. The thermostability and material properties of amy-
loid-like oligomers composed of WT and mutant SOD1 are
unmeasured. In fact, we could find only one study that
analyzed the thermostability of amyloid fibrils of any pro-
tein with DSC. This study showed that Tm ¼ 83C for am-
yloid fibrils of the N47A mutant of alpha-spectrin SH3
domain, compared with Tm ¼ 49C for the protein’s native
state (52). Nevertheless, it is reasonable to hypothesize that
an amyloid oligomer could be made less toxic by super-
charging the fibril, assuming that supercharging destabilized
the fibril to a level that rendered it a substrate for intra- or
extracellular proteases, and diminished its permeability
(electrostatically) across anionic cellular membranes. This
type of successive supercharging after fibrillization, by
repeated doses of an acylating agent, might represent a prac-
tical medicinal approach because the long half-life of amy-
loid-like oligomers would permit accumulation of chemical
modifications (29).Biophysical Journal 108(5) 1199–1212
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of acetylated and unacetylated apo-SOD1 fibrils was modi-
fied from Shammas and coworkers (32) and is illustrated
in Fig. S15 A. We chose to measure the stability of fibrils us-
ing thermal defibrillization, instead of chemical defibrilliza-
tion, because the interaction of chemical denaturants (such
as guanidinium hydrochloride, sodium dodecyl sulfate, or
urea) can be dependent on the net charge and hydrophobic-
ity of proteins, both of which are altered by acetylation of
Lys-NH3
þ to Lys-NHCOCH3 (53,54). We assume that the
low pressure generated in this thermal defibrillization assay
(~350 kPa) had a negligible effect on the thermostability of
fibrils because it is 1000-fold lower than minimal values re-
ported to induce protein aggregation (i.e., ~400 MPa) (55).
The Tm of SOD1 amyloid fibrils composed of unacetylated
apo-SOD1 were 99.425 0.89C for WT, 104.695 0.24C
for D90A, and 99.855 0.48C for A4V (Fig. S15, B–D, and
Table S5). Maximal acetylation of lysine residues in apo-
SOD1 with aspirin, before fibrillization, decreased the Tm
of resulting fibrils by between ~3C and 7C (Table S5):
DTm ¼ 3.155 1.1C for WT-Ac(0) and WT-Ac(~6) am-
yloid; DTm ¼ 7.075 0.64C for D90A-Ac(0) and D90A-
Ac(~5) amyloid; DTm ¼ 4.78 5 0.58C for A4V-Ac(0)
and A4V-Ac(~9) amyloid SOD1. These differences in the
Tm values of unacetylated and acetylated fibrils were statis-
tically significant for all three proteins, with ***p-values
uniformly < 0.0001. In general, successive acetylation of
native SOD1 diminished the Tm of resulting fibrils; however,
the differences in the Tm of fibrils from proteins that differed
in mean acetylation by less than approximately three lysines
were often statistically indistinguishable (Table S5). This
result might be caused by similarities (overlap) in the distri-
bution of acetylated lysines among different samples. For
example, the Tm of fibrillar D90A SOD1-Ac(~3) ¼ 96.02
5 0.97C, whereas the Tm of fibrillar D90A SOD1-
Ac(~5) ¼ 97.62 5 0.60C (Table S5). Although these two
sets of proteins have different mean numbers of acetylated
lysine, these two sets have ~70% overlap in the distribution
of acetylated species (Fig. S5, A, B, and E), and this similar
degree of acetylation might account for the statistically
similar values of Tm.
To ensure that the total concentration of apo-SOD1 protein
did not change during the course of heating (via solvent evap-
oration) we performed reducing SDS-PAGE on solutions
before thermal defibrillization and after thermal defibrilliza-
tion. We observed no significant difference in apo-SOD1
concentration before and after heating (Fig. S15 E), indi-
cating that protein concentration did not change via solvent
evaporation during thermal defibrillization.
Although the turbidity of each fibrillar solution was
abolished at the end of each thermal scan, it is possible
that fibrils of apo-SOD1 melted incompletely into small
oligomeric forms that did not sediment or scatter light, but
are nonetheless still in an amyloid state. To assay for such
small oligomers, we performed size-exclusion liquid chro-Biophysical Journal 108(5) 1199–1212matography (SE-LC) and native PAGE on solutions at
the end of thermal defibrillization experiment (Fig. S16,
A–C). The supernatant solutions of melted fibrils from all
three apo-SOD1 proteins contained SOD1 species that
were <50 kDa, according to SE-LC calibration curve
(Fig. S16 B). All three apo-SOD1 proteins did, however,
migrate slower than the dimeric form of soluble WT apo-
SOD1 during native PAGE (Fig. S16 C), which might be
caused by improper refolding after cooling the thermally de-
fibrillized and denatured polypeptides.
We also filtered the supernatants of melted fibrils with a
0.2 mm filter and performed SE-LC, native PAGE, and trans-
mission electron microscopy (TEM) and found no significant
difference in the chromatography, electrophoresis, or micro-
scopy of nonfiltered and filtered samples, which suggested
that oligomers that are>0.2 mm in diameter were not present
after thermal defibrillization (Fig. S16, A,C, andD). Fibrillar
species were not detected by TEM in these heated samples,
even after examining ~3.5 mm2 of the grid surface in three
separate replicate analyses (Fig. S16 D). Thus, the assay
we used to measure the Tm of fibrillar apo-SOD1 appears
to be a valid method for determining the stability of the large
SOD1 fibrils depicted in TEM images of Fig. 5 E. In conclu-
sion, the predominant amyloid framework of fibrillar apo-
SOD1 is not as thermostable as we expected and does not
represent a thermodynamic black hole for SOD1. For
example, the Tm of unacetylated WT apo-SOD1 fibrils is
only a few degrees higher than the Tm of the properly folded
and fully metalated WT Cu2;Zn2-SOD1 protein (56). More-
over, the fibrils formed in this study did not appear to involve
extensive intermolecular disulfide crosslinks (57), i.e., the
thermal defibrillization assay did not include any reducing
agent and fibrils nevertheless dissociated to species with mo-
lecular weights%50 kDa (Fig. S16).Lysine, serine, and threonine residues in amyloid
apo-SOD1 are reactive with aspirin
We also wanted to determine if lysine residues in amyloid
apo-SOD1 could be acetylated with aspirin after fibrilliza-
tion of unacetylated apo-SOD1, and the degree to which
these modifications affect fibril thermostability.
To determine the reactivity of fibrils, we prepared amy-
loid fibrils of WT- and ALS-variant apo-SOD1 from each
unacetylated protein and reacted the amyloid fibrils with
aspirin in aqueous buffer. The number of acetylated lysines
in fibrillized apo-SOD1 polypeptides was determined by
thermochemically dissociating fibrils and analyzing the
dissociated polypeptides with electrospray ionization MS
(Fig. 6, A–C). Fibrils were gently dissociated by heating at
50C, in 6.5 M guandinium hydrochloride (Gdm-HCl),
20 mM dithiothreitol (DTT), pH 8. This protocol has been
proven to dissociate fibrils of SOD1 into monomeric poly-
peptides that can be analyzed with electrospray ionization
mass spectrometry (31).
FIGURE 6 Effect of peracetylation of lysine in
fibrillar WT- and ALS-variant apo-SOD1 on fibril
thermostability (i.e., acetylation after fibrillization).
(A–C) Mass spectra of unacetylated (left panel),
and peracetylated (right panel) WT- and ALS-
variant apo-SOD1 thermochemically dissociated
from amyloid fibrils (acetylation was performed af-
ter fibrillization). (D–F) Thermal stability curves of
unacetylated (blue solid squares) and peracetylated
(red solid squares) WT, D90A, and A4Vapo-SOD1
amyloid fibrils. To see this figure in color, go
online.
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thermochemically dissociated fibrils demonstrated that
each of the 11 lysine residues in apo-SOD1 amyloid fibrils
could be acetylated by aspirin (Fig. 6, A–C, right panels).
Thus, unlike the native soluble protein, we were able to acet-
ylate all 11 lysine residues in fibrillar apo-SOD1; the forma-
tion of amyloid by SOD1 does not cause its lysines to be
protected from chemical modification. MS also showed
that a significant population of SOD1 proteins contained
additional acetyl modifications (up to seven additional
acetyl groups) on residues other than lysine (Fig. 6, A–C,
right panels). We were able to identify acetyl modifications
on each lysine with MS-MS analysis (Fig. S17 A), and also
detected acetyl groups on Ser-134, Ser-142, Thr-135, and
Thr-137 (Fig. S17 B). We hypothesize that these types of
Ser and Thr modifications were not detected (and were pre-
sumably not present) in acetylated native WT and D90A
apo-SOD1 because 1) native forms of these proteins precip-
itated before a sufficient excess of aspirin could be added to
acetylate Ser and Thr (this impediment did not occur when
acetylating amyloid fibrils); and/or 2) fibrillization pro-tected ester groups on Ser and Thr from hydrolysis (that
might occur during analysis).Peracetylation of lysine in amyloid (after
fibrillization) increases formal net charge by
millions of units and lowers fibril thermostability
Thermostability assays for peracetylated amyloid fibrils of
WT, D90A, and A4Vapo-SOD1 (that were peracetylated af-
ter fibrillization) are shown in Fig. 6, D–F; fibril Tm values
are listed in Table S5. Peracetylation lowered the Tm of
D90A fibrils by three- to fourfold more than A4V or WT
fibrils. Peracetylation lowered fibril Tm by DTm ¼ 7.76
5 1.18C for WT fibrils; DTm ¼ 20.2 5 0.48C for
D90A fibrils; DTm ¼ 4.56 5 0.69C for A4V fibrils
(Fig. 6, D–F, and Table S5).
We point out that the Tm of peracetylated fibrils of D90A
(Tm ¼ 84.495 0.42C), A4V (Tm ¼ 95.295 0.50C), and
WT SOD1 (Tm¼ 91.665 0.78C) are near or below the re-
ported Tm for the WT holo-SOD1 enzyme (Cu2;Zn2-SOD1)
in its native state (Tm ~90
C to 95C) (56). These low TmBiophysical Journal 108(5) 1199–1212
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stable, acetylated fibrils might have sufficient instability
for proteolysis by intracellular or extracellular proteases
(58). We also point out that any SOD1 oligomers or poly-
peptides that would dissociate from these unstable fibrils
would be less prone to seed aggregation (than unacetylated
polypeptides), because of their supercharged state.
The most straightforward explanation for why peracetyla-
tion diminished the thermostability of amyloid SOD1 is that
peracetylation strengthened the repulsive Coulombic forces
between similarly charged—now supercharged—SOD1
polypeptides. The peracetylation of an amyloid fibril with
dimensions of 15 nm by 2 mm (composed of ~1.9  105
SOD1 polypeptide chains) will increase the net negative
charge of the fibril by ~1.6  106 units of formal charge
at pH 7.4. See Supporting Material for details of this
calculation.CONCLUSIONS
The results of this study do not suggest that an acylating
agent such as aspirin—which nonspecifically acetylates
SOD1—can function as a charge-boosting drug in the treat-
ment of ALS. Instead, future work will be required to design
and synthesize compounds that selectively boost the net
charge of SOD1 (or its oligomers). We envision the general
chemical anatomy of a selective charge booster to consist of
a head for molecular recognition of the target protein or pro-
tein oligomer (Fig. S18), and a reactive acylating tail that ac-
ylates nearby lysine residues. One advantage to designing
small reactive molecules that increase the net charge of a
target protein, as opposed to designing conventional ligands
that noncovalently stabilize the structure of the native or
oligomeric protein, is that the former might be much easier
to accomplish (medicinally). The acetylation of lysines in
WTor mutant apo-SOD1 by aspirin inhibited the nucleation
and propagation of amyloid fibrils, even though the acetyla-
tion was nonspecific. This result suggests that increasing the
net surface potential of different surface loci—perhaps acet-
ylating any surface lysine on a small anionic protein such as
SOD1—will inhibit aggregation. This large number of
chemical targets in a single protein is in stark contrast to
the chemical constraints that typify conventional medicinal
chemistry. It is also important to remember that this study
demonstrated the basic tenet of the charge-boosting strategy
by using the least potent, electrostatically speaking, type of
chemistry, i.e., DZ ¼ 1 per modification.
The interactions between highly charged proteins and
cellular membranes were not examined in this study. Never-
theless, it is reasonable to hypothesize that a hyperanionic,
acetylated SOD1 protein (oligomeric or native) will resist
electrostatic interactions with inner and outer cellular mem-
branes (which are generally anionic because of sialylated
and sulfated glycans (59)) more than unacetylated SOD1
proteins. For example, it has been shown that superchargedBiophysical Journal 108(5) 1199–1212green fluorescent protein with magnitudes of negative
charge reaching Z ¼ 30 are resistant to association with
outer cellular membranes, whereas supercharged proteins
with Z ¼ þ36 permeate the same cellular membranes
(21). Increasing the electrostatic repulsion between cellular
membranes and SOD1 proteins might diminish the cell-to-
cell propagation of oligomeric SOD1 (20,60) and halt the
progressive death of motor neurons in ALS.SUPPORTING MATERIAL
Supporting Materials and Methods, Supporting Results and Discussion, 18
figures, and five tables are available at http://www.biophysj.org/biophysj/
supplemental/S0006-3495(15)00077-6.
AUTHOR CONTRIBUTIONS
A.A. and B.F.S. organized the research. All the authors contributed to the
design of the experiments, the analysis of the data, and editing of the
manuscript.ACKNOWLEDGMENTS
Financial support for this research was provided to B.F.S. by the Depart-
ment of Defense (W81XWH-11-1-0790), the National Science Foundation
(CAREER CHE: 1352122), and the Welch Foundation (AA-1854).
SUPPORTING CITATIONS
References (61–63) appear in the Supporting Material.REFERENCES
1. Roberts, D., R. Keeling,., R. Curtis. 2014. The role of electrostatics
in protein-protein interactions of a monoclonal antibody. Mol. Pharm.
11:2475–2489.
2. Gitlin, I., J. D. Carbeck, and G. M. Whitesides. 2006. Why are proteins
charged? Networks of charge-charge interactions in proteins measured
by charge ladders and capillary electrophoresis. Angew. Chem. Int. Ed.
Engl. 45:3022–3060.
3. Lessene, G., P. E. Czabotar,., K. G. Watson. 2013. Structure-guided
design of a selective BCL-X(L) inhibitor. Nat. Chem. Biol. 9:390–397.
4. Lee, S., X. Zheng,., M. H. Lim. 2014. Rational design of a structural
framework with potential use to develop chemical reagents that target
and modulate multiple facets of Alzheimer’s disease. J. Am. Chem. Soc.
136:299–310.
5. Shahian, T., G. M. Lee, ., C. S. Craik. 2009. Inhibition of a viral
enzyme by a small-molecule dimer disruptor. Nat. Chem. Biol.
5:640–646.
6. Sreedharan, J., and R. H. Brown, Jr. 2013. Amyotrophic lateral scle-
rosis: problems and prospects. Ann. Neurol. 74:309–316.
7. Jiang, L., C. Liu,., D. S. Eisenberg. 2013. Structure-based discovery
of fiber-binding compounds that reduce the cytotoxicity of amyloid
beta. eLife. 2:e00857.
8. Grisolia, S., I. Santos, and J. Mendelson. 1968. Inactivation of enzymes
by aspirin and salicylate. Nature. 219:1252.
9. Alfonso, L., G. Ai, ., G. J. Bhat. 2014. Molecular targets of aspirin
and cancer prevention. Br. J. Cancer. 111:61–67.
10. Bateman, L. A., B. W. Zaro,., M. R. Pratt. 2013. An alkyne-aspirin
chemical reporter for the detection of aspirin-dependent protein modi-
fication in living cells. J. Am. Chem. Soc. 135:14568–14573.
Net Charge as a Druggable Target 121111. Barne´oud, P., and O. Curet. 1999. Beneficial effects of lysine acetylsa-
licylate, a soluble salt of aspirin, on motor performance in a transgenic
model of amyotrophic lateral sclerosis. Exp. Neurol. 155:243–251.
12. Choudhary, C., B. T. Weinert,., M. Mann. 2014. The growing land-
scape of lysine acetylation links metabolism and cell signalling. Nat.
Rev. Mol. Cell Biol. 15:536–550.
13. Chiti, F., and C. M. Dobson. 2009. Amyloid formation by globular pro-
teins under native conditions. Nat. Chem. Biol. 5:15–22.
14. Lawrence, M. S., K. J. Phillips, and D. R. Liu. 2007. Supercharging
proteins can impart unusual resilience. J. Am. Chem. Soc.
129:10110–10112.
15. Osborne, T. B. 1902. The basic character of the protein molecule and
the reactions of edestin with definite quantities of acids and alkalies.
J. Am. Chem. Soc. 24:39–78.
16. Csonka, F. A., J. C. Murphy, and D. B. Jones. 1926. The iso-electric
points of various proteins. J. Am. Chem. Soc. 48:763–768.
17. Felder, C. E., J. Prilusky, ., J. L. Sussman. 2007. A server and data-
base for dipole moments of proteins. Nucleic Acids Res. 35:W512–
W521.
18. Shaw, B. F., G. F. Schneider,., G. M. Whitesides. 2008. Lysine acet-
ylation can generate highly charged enzymes with increased resistance
toward irreversible inactivation. Protein Sci. 17:1446–1455.
19. Shaw, B. F., D. T. Moustakas, ., K. F. Faull. 2010. Taking charge of
proteins: from neurodegeneration to industrial biotechnology. Adv.
Protein Chem. Struct. Biol. 79:127–164.
20. Mu¨nch, C., J. O’Brien, and A. Bertolotti. 2011. Prion-like propagation
of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc.
Natl. Acad. Sci. USA. 108:3548–3553.
21. McNaughton, B. R., J. J. Cronican, ., D. R. Liu. 2009. Mammalian
cell penetration, siRNA transfection, and DNA transfection by super-
charged proteins. Proc. Natl. Acad. Sci. USA. 106:6111–6116.
22. Sandelin, E., A. Nordlund, ., M. Oliveberg. 2007. Amyotrophic
lateral sclerosis-associated copper/zinc superoxide dismutase muta-
tions preferentially reduce the repulsive charge of the proteins.
J. Biol. Chem. 282:21230–21236.
23. Rodriguez, J. A., B. F. Shaw,., J. S. Valentine. 2005. Destabilization
of apoprotein is insufficient to explain Cu,Zn-superoxide dismutase-
linked ALS pathogenesis. Proc. Natl. Acad. Sci. USA. 102:10516–
10521.
24. Shi, Y., A. Abdolvahabi, and B. F. Shaw. 2014. Protein charge ladders
reveal that the net charge of ALS-linked superoxide dismutase can be
different in sign and magnitude from predicted values. Protein Sci.
23:1417–1433.
25. Shi, Y., R. A. Mowery, and B. F. Shaw. 2013. Effect of metal loading
and subcellular pH on net charge of superoxide dismutase-1. J. Mol.
Biol. 425:4388–4404.
26. Della Valle, M. C., D. E. Sleat,., P. Lobel. 2011. Classification of sub-
cellular location by comparative proteomic analysis of native and den-
sity-shifted lysosomes. Mol. Cell. Proteomics. 10. http://dx.doi.org/10.
1074/mcp.M110 006403.
27. Shi, Y., N. R. Rhodes,., B. F. Shaw. 2013. Deamidation of asparagine
to aspartate destabilizes Cu, Zn superoxide dismutase, accelerates fi-
brillization, and mirrors ALS-linked mutations. J. Am. Chem. Soc.
135:15897–15908.
28. Pepys, M. B. 2006. Amyloidosis. Annu. Rev. Med. 57:223–241.
29. Maji, S. K., D. Schubert,., R. Riek. 2008. Amyloid as a depot for the
formulation of long-acting drugs. PLoS Biol. 6:e17.
30. Shi, Y., R. A. Mowery, ., B. F. Shaw. 2012. Abnormal SDS-PAGE
migration of cytosolic proteins can identify domains and mechanisms
that control surfactant binding. Protein Sci. 21:1197–1209.
31. Chattopadhyay, M., A. Durazo,., J. S. Valentine. 2008. Initiation and
elongation in fibrillation of ALS-linked superoxide dismutase. Proc.
Natl. Acad. Sci. USA. 105:18663–18668.
32. Shammas, S. L., T. P. Knowles,., G. L. Devlin. 2011. Perturbation of
the stability of amyloid fibrils through alteration of electrostatic inter-
actions. Biophys. J. 100:2783–2791.33. Erickson, H. P. 2009. Size and shape of protein molecules at the nano-
meter level determined by sedimentation, gel filtration, and electron
microscopy. Biol. Proced. Online. 11:32–51.
34. Shaw, B. F., A. Durazo,., J. S. Valentine. 2006. Local unfolding in a
destabilized, pathogenic variant of superoxide dismutase 1 observed
with H/D exchange and mass spectrometry. J. Biol. Chem. 281:
18167–18176.
35. LeVine, 3rd, H. 1999. Quantification of beta-sheet amyloid fibril struc-
tures with thioflavin T. Methods Enzymol. 309:274–284.
36. Vali, G. 2008. Repeatability and randomness in heterogeneous freezing
nucleation. Atmos. Chem. Phys. 8:5017–5031.
37. Prindle, A., and J. Hasty. 2010. Biochemistry. Stochastic emergence of
groupthink. Science. 328:987–988.
38. Xue, W. F., S. W. Homans, and S. E. Radford. 2008. Systematic anal-
ysis of nucleation-dependent polymerization reveals new insights into
the mechanism of amyloid self-assembly. Proc. Natl. Acad. Sci. USA.
105:8926–8931.
39. Fodera`, V., F. Librizzi,., M. Leone. 2008. Secondary nucleation and
accessible surface in insulin amyloid fibril formation. J. Phys. Chem. B.
112:3853–3858.
40. Morris, R. J., K. Eden,., C. E. MacPhee. 2013. Mechanistic and envi-
ronmental control of the prevalence and lifetime of amyloid oligomers.
Nat. Commun. 4:1891.
41. Hortschansky, P., V. Schroeckh, ., M. Fa¨ndrich. 2005. The aggrega-
tion kinetics of Alzheimer’s beta-amyloid peptide is controlled by sto-
chastic nucleation. Protein Sci. 14:1753–1759.
42. Ghag, G., P. Ghosh,., A. Vaidya. 2013. Stability analysis of 4-species
Ab aggregation model: a novel approach to obtaining physically mean-
ingful rate constants. Appl. Math. Comput. 224:205–215.
43. Hellstrand, E., B. Boland,., S. Linse. 2010. Amyloid b-protein aggre-
gation produces highly reproducible kinetic data and occurs by a two-
phase process. ACS Chem. Neurosci. 1:13–18.
44. Oxtoby, D. W. 1993. Nonclassical nucleation theory: an exactly soluble
model. Phys. Scr. 1993:65.
45. Oxtoby, D. W. 1998. Nucleation of first-order phase transitions. Acc.
Chem. Res. 31:91–97.
46. Rotunno, M. S., and D. A. Bosco. 2013. An emerging role for mis-
folded wild-type SOD1 in sporadic ALS pathogenesis. Front. Cell.
Neurosci. 7:253.
47. Buell, A. K., P. Hung,., T. P. Knowles. 2013. Electrostatic effects in
filamentous protein aggregation. Biophys. J. 104:1116–1126.
48. Chan, P. K., M. Chattopadhyay, ., J. S. Valentine. 2013. Structural
similarity of wild-type and ALS-mutant superoxide dismutase-1 fibrils
using limited proteolysis and atomic force microscopy. Proc. Natl.
Acad. Sci. USA. 110:10934–10939.
49. Shaw, B. F., H. Arthanari, ., G. M. Whitesides. 2010. Neutralizing
positive charges at the surface of a protein lowers its rate of amide
hydrogen exchange without altering its structure or increasing its ther-
mostability. J. Am. Chem. Soc. 132:17411–17425.
50. Abdolvahabi, A., J. L. Gober,., B. F. Shaw. 2014. Metal-ion-specific
screening of charge effects in protein amide H/D exchange and the
Hofmeister series. Anal. Chem. 86:10303–10310.
51. Lorenzen, N., and D. E. Otzen. 2013. Inhibition of amyloid formation
by small molecules. In Amyloid Fibrils and Prefibrillar Aggregates:
Molecular and Biological Properties. D. E. Otzen, editor. Wiley-
VCH Verlag, Weinheim, Germany, pp. 350–356.
52. Morel, B., L. Varela, and F. Conejero-Lara. 2010. The thermodynamic
stability of amyloid fibrils studied by differential scanning calorimetry.
J. Phys. Chem. B. 114:4010–4019.
53. Gitlin, I., K. L. Gudiksen, and G. M. Whitesides. 2006. Effects of sur-
face charge on denaturation of bovine carbonic anhydrase. ChemBio-
Chem. 7:1241–1250.
54. Shaw, B. F., G. F. Schneider,., G. M.Whitesides. 2011. Complexes of
native ubiquitin and dodecyl sulfate illustrate the nature of hydrophobic
and electrostatic interactions in the binding of proteins and surfactants.
J. Am. Chem. Soc. 133:17681–17695.Biophysical Journal 108(5) 1199–1212
1212 Abdolvahabi et al.55. Seefeldt, M. B., Y. S. Kim, ., T. W. Randolph. 2005. High-pressure
studies of aggregation of recombinant human interleukin-1 receptor
antagonist: thermodynamics, kinetics, and application to accelerated
formulation studies. Protein Sci. 14:2258–2266.
56. Rodriguez, J. A., J. S. Valentine, ., L. J. Hayward. 2002. Familial
amyotrophic lateral sclerosis-associated mutations decrease the ther-
mal stability of distinctly metallated species of human copper/zinc su-
peroxide dismutase. J. Biol. Chem. 277:15932–15937.
57. Banci, L., I. Bertini,., J. P. Whitelegge. 2007. Metal-free superoxide
dismutase forms soluble oligomers under physiological conditions: a
possible general mechanism for familial ALS. Proc. Natl. Acad. Sci.
USA. 104:11263–11267.
58. Nijholt, D. A., L. De Kimpe,., W. Scheper. 2011. Removing protein
aggregates: the role of proteolysis in neurodegeneration. Curr. Med.
Chem. 18:2459–2476.
59. Cooper, G. M., and R. E. Hausman. 2013. The Cell: A Molecular
Approach. Sinauer Associates, Sunderland, MA.Biophysical Journal 108(5) 1199–121260. Grad, L. I., J. J. Yerbury,., N. R. Cashman. 2014. Intercellular prop-
agated misfolding of wild-type Cu/Zn superoxide dismutase occurs via
exosome-dependent and -independent mechanisms. Proc. Natl. Acad.
Sci. USA. 111:3620–3625.
61. Kokot, Z., and K. Burda. 1998. Simultaneous determination of salicylic
acid and acetylsalicylic acid in aspirin delayed-release tablet formula-
tions by second-derivative UV spectrophotometry. J. Pharm. Biomed.
Anal. 18:871–875.
62. Anderson, J. R., O. Chemiavskaya, ., G. M. Whitesides. 2002.
Analysis by capillary electrophoresis of the kinetics of charge lad-
der formation for bovine carbonic anhydrase. Anal. Chem. 74:1870–
1878.
63. Furukawa, Y., and T. V. O’Halloran. 2005. Amyotrophic lateral scle-
rosis mutations have the greatest destabilizing effect on the apo- and
reduced form of SOD1, leading to unfolding and oxidative aggregation.
J. Biol. Chem. 280:17266–17274.
